Laboratorios Farmaceuticos Rovi SA (XMAD:ROVI)
€ 88.2 0.4 (0.46%) Market Cap: 4.51 Bil Enterprise Value: 4.55 Bil PE Ratio: 33.54 PB Ratio: 8.47 GF Score: 88/100

Half Year 2019 Laboratorios Farmaceuticos ROVI SA Earnings Call Transcript

Jul 30, 2019 / 01:00PM GMT
Release Date Price: €21.1 (+2.93%)
Operator

Good day, ladies and gentlemen. Thank you for standing by, and welcome to the ROVI First Half 2019 Financial Results Call. (Operator Instructions)

And I must advise you that this call is being recorded today, Tuesday, 30th of July, 2019. And without any further delay, I would now like to turn the call over to your speaker today, Mr. Javier Lopez-Belmonte. Thank you, please go ahead.

Javier Lopez;Belmonte Encina
Laboratorios Farmaceuticos Rovi, S.A. - First Deputy Chairman & CFO

Thank you very much, and good afternoon to everyone. This is Javier Lopez-Belmonte, CFO of ROVI. At this time, I would like to welcome everybody to this first half 2019 results conference call, which we'll start in a moment. Let me please first introduce ROVI's attendees today, Juan Lopez-Belmonte, CEO; Marta Campos, Investor Relations; and myself. All lines are now mute to prevent any background noise.

The conference will also be webcasted on ROVI's website. After the presentation, as the operator said, there will be a question-and-answer session

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot